PURCHASE, N.Y., Feb 12, 2003 (BUSINESS WIRE) -- IntegraMed America, Inc.
(Nasdaq: INMD) today announced that the Company will release fourth quarter and
year 2002 financial results on Wednesday, February 19, 2003, after the close of
the financial markets.
Gerardo Canet, president and chief executive officer, and John Hlywak, Jr.,
chief financial officer, will host an investment-community conference call
beginning Thursday, February 20, 2003, at 10:00 a.m. Eastern Time to discuss
those results and to answer questions. It is anticipated that other Senior
officers of the Company will also participate in the call.
To participate in the live call via telephone, please call (888) 803-7481
(domestic) or (706) 634-1308 (international). A telephone replay will be
available through 12:00 p.m. Eastern Time, February 24 by dialing (800) 642-1687
(domestic) or (706) 645-9291 (international) and entering reservation number
Individuals interested in listening to the conference call via the Internet may
do so by visiting the Company's web site at www.integramed.com. A replay will be
available on the web site for 14 days.
IntegraMed America, based in Purchase, N.Y., is focused on the $2 billion
infertility industry, and offers products and services to patients, providers,
payers and manufacturers. Specifically, the Company provides Business Services
to a network of Fertility Centers; distributes pharmaceutical products and
financing programs directly to patients; operates www.integramed.com, an
award-winning infertility Web site; and conducts clinical research through
IntegraMed Research Institute.
Statements contained in this press release that are not based on historical
fact, including statements concerning future results, performance, expectations
and expansion of IntegraMed America are forward-looking statements. Actual
results may differ materially from the statements made as a result of various
factors including, but not limited to, the risks associated with the Company's
ability to finance future growth; the loss of significant management
contract(s); profitability at Reproductive Science Centers managed by IntegraMed
America; changes in insurance coverage, government laws and regulations
regarding health care or managed care contracting; and other risks, including
those identified in the Company's most recent Form 10-K and in other documents
filed by the Company with the U.S. Securities and Exchange Commission (SEC).
IntegraMed America, Inc.
John W. Hlywak, Jr., 914/251-4143
Jay Higham, 914/251-4127
Lippert/Heilshorn & Associates
Kim Golodetz, 212/838-3777
Bruce Voss, 310/691-7100